Neuropsychopharmacology
- The why, when, where, how, and so what of so-called rapidly acting antidepressants1 year ago
- In memoriam: S. J. Enna, PhD, December 19, 1944–June 15, 20231 year ago
- CB1R blockade unmasks TRPV1-mediated contextual fear generalization in female, but not male rats1 year ago
- Chemogenetic activation of corticotropin-releasing factor-expressing neurons in the anterior bed nucleus of the stria terminalis reduces effortful motivation behaviors1 year ago
- Potentiation of AMPA receptors for rapid therapeutic gain in psychiatry has reached a new level of excitement1 year ago
- Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication1 year ago
- A non-human primate model of cocaine addiction: interpreting associations with increased vs. decreased dopamine function1 year ago
Journal of Psychopharmacology
- Three regulatory compliant test systems show no signs of MDMA-related genotoxicity3 years ago
- Over the counter low-dose cannabidiol: A viewpoint from the ACRE Capacity Building Group3 years ago
- Which are the demographic and clinical characteristics of patients who respond to subcutaneous esketamine?3 years ago
- Effects of benzodiazepine and orexin receptor antagonist on cognitive function revealed by auditory event-related potentials3 years ago
- The Journal of Psychopharmacology: La Plus ça change. . .3 years ago
- β-adrenoceptor antagonists and nightmares: A pharmacoepidemiological–pharmacodynamic study3 years ago
- Prospects for new drugs to treat binge-eating disorder: Insights from psychopathology and neuropharmacology3 years ago
European Neuropsychopharmacology
- Evaluating study designs and treatment outcomes of antidepressant pharmacogenetic clinical trials – Challenges and future perspectives. A critical review2 years ago
- Letter to the editor about the article “Psychiatric disorders in post-acute COVID-syndrome 3 (PDPACS): Recommendations for health care professionals” (Falconi A et al., 2022)2 years ago
- Cannabidiol enhancement of exposure therapy in treatment refractory patients with social anxiety disorder and panic disorder with agoraphobia: A randomised controlled trial2 years ago
- The transition from adolescence to adulthood in patients with schizophrenia: Challenges, opportunities and recommendations2 years ago
- Depression, antidepressants, and insulin resistance: which link?2 years ago
- Comparative effectiveness of antipsychotic monotherapy and polypharmacy in schizophrenia patients with clozapine treatment: A nationwide, health insurance data-based study2 years ago
- Association between CACNA1C gene rs100737 polymorphism and glutamatergic neurometabolites in bipolar disorder2 years ago
Psychopharmacology
- Insufficient autophagy enables the nuclear factor erythroid 2-related factor 2 (NRF2) to promote ferroptosis in morphine-treated SH-SY5Y cells10 months ago
- Effects of cannabidiol on fear conditioning in anxiety disorders: decreased threat expectation during retention, but no enhanced fear re-extinction10 months ago
- Effects of cannabidiol on fear conditioning in anxiety disorders: decreased threat expectation during retention, but no enhanced fear re-extinction10 months ago
- Removal of the ovaries suppresses ethanol drinking and promotes aversion-resistance in C57BL/6J female mice10 months ago
- Norepinephrine depletion in the brain sex-dependently modulates aspects of spatial learning and memory in female and male rats10 months ago
- Facial expressions of pain: the role of the serotonergic system10 months ago
- Alkoxy chain length governs the potency of 2-benzylbenzimidazole ‘nitazene’ opioids associated with human overdose10 months ago
International Journal of Neuropsychopharmacology
- Clinical and Clinical-Pharmacogenetic Models for Prediction of the Most Common Psychiatric Complications Due to Dopaminergic Treatment in Parkinson’s Disease4 years ago
- Tandospirone, a Partial 5-HT1A Receptor Agonist, Administered Systemically or Into Anterior Cingulate Attenuates Repetitive Behaviors in Shank3B Mice4 years ago
- Translational Development Strategies for TAK-063, a Phosphodiesterase 10A Inhibitor4 years ago
- Ketogenic Therapy in Serious Mental Illness: Emerging Evidence4 years ago
- Treatment Response of Add-On Esketamine Nasal Spray in Resistant Major Depression in Relation to Add-On Second-Generation Antipsychotic Treatment4 years ago
- The Molecular-Container Calabadion-2 Prevents Methamphetamine-Induced Reinstatement in Rats: A Potential Approach to Relapse Prevention?4 years ago
- Molecular-container Calabadion-2: Can Sweeping the Brain of Drugs Promote Abstinence?4 years ago
Frontiers in Pharmacology
- Dimethyl fumarate abrogates striatal endoplasmic reticulum stress in experimentally induced late-stage Huntington’s disease: Focus on the IRE1α/JNK and PERK/CHOP trajectories2 years ago
- Neuroprotection of NAD+ and NBP against ischemia/reperfusion brain injury is associated with restoration of sirtuin-regulated metabolic homeostasis2 years ago
- Corrigendum: Three naturally-occurring psychedelics and their significance in the treatment of mental health disorders2 years ago
- Editorial: Experimental models of epilepsy and related comorbidities, Volume II2 years ago
- Fraxetin attenuates disrupted behavioral and central neurochemical activity in a model of chronic unpredictable stress2 years ago
- The role of SUMOylation in the neurovascular dysfunction after acquired brain injury2 years ago
- A bibliometrics analysis and visualization study of TRPV1 channel2 years ago
Translational Psychiatry
- Hydroxynorketamine, but not ketamine, acts via α7 nicotinic acetylcholine receptor to control presynaptic function and gene expression8 months ago
- Multivariate patterns of brain functional connectome associated with COVID-19-related negative affect symptoms8 months ago
- Synaptic and mitochondrial mechanisms behind alcohol-induced imbalance of excitatory/inhibitory synaptic activity and associated cognitive and behavioral abnormalities8 months ago
- Development of an individualized risk calculator of treatment resistance in patients with first-episode psychosis (TRipCal) using automated machine learning: a 12-year follow-up study with clozapine prescription as a proxy indicator8 months ago
- Genetic evidence for the causal relations between metabolic syndrome and psychiatric disorders: a Mendelian randomization study8 months ago
- Early life stress and body-mass-index modulate brain connectivity in alcohol use disorder8 months ago
- Longitudinal hippocampal subfield development associated with psychotic experiences in young people8 months ago
Molecular Psychiatry
- Connectome dysfunction in patients at clinical high risk for psychosis and modulation by oxytocin8 months ago
- Addiction biotypes: a paradigm shift for future treatment strategies?8 months ago
- Association between alcohol consumption and sleep traits: observational and mendelian randomization studies in the UK biobank9 months ago
- Risk for diagnosis or treatment of mood or anxiety disorders in adults after SARS-CoV-2 infection, 2020–20229 months ago
- A network model of depressive and anxiety symptoms: a statistical evaluation9 months ago
- High-resolution tracking of unconfined zebrafish behavior reveals stimulatory and anxiolytic effects of psilocybin9 months ago
- The amygdala NT3-TrkC pathway underlies inter-individual differences in fear extinction and related synaptic plasticity9 months ago
Nature Reviews Neuroscience
CNS Spectrum
- Violent behavior and the COVID-19 lockdowns: a nationwide register-based study2 years ago
- Open innovation: the key to advancing brain health2 years ago
- Treatment response to esketamine nasal spray in patients with major depressive disorder and acute suicidal ideation or behavior without evidence of early response: a pooled post hoc analysis of ASPIRE2 years ago
- Inpatient suicide: epidemiology, risks, and evidence-based strategies2 years ago
- The prescriber’s guide to classic MAO inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depression2 years ago
- Psilocybin in neuropsychiatry: a review of its pharmacology, safety, and efficacy2 years ago
- Assessing the educational needs of physicians in the management of patients with Tourette syndrome: results of a United States survey on practicing clinicians and caregivers – Corrigendum2 years ago
Neuropharmacology
- Trimethoxyflavanone relieves Paclitaxel-induced neuropathic pain via inhibiting expression and activation of P2X7 and production of CGRP in mice1 year ago
- Adjusting the brakes to adjust neuronal activity: Adenosinergic modulation of GABAergic transmission1 year ago
- Impaired cognitive control after moderate prenatal alcohol exposure corresponds to altered EEG power during a rodent touchscreen continuous performance task1 year ago
- Repetitive transcranial magnetic stimulation and fluoxetine reverse depressive-like behavior but with differential effects on Olig2-positive cells in chronically stressed mice1 year ago
- Lactoferrin averts neurological and behavioral impairments of thioacetamide-induced hepatic encephalopathy in rats via modulating HGMB1/TLR-4/MyD88/Nrf2 pathway1 year ago
- Kanamycin treatment in the pre-symptomatic stage of a Drosophila PD model prevents the onset of non-motor alterations1 year ago
- Editorial Board1 year ago
Nature
- Holistic approach to carbon capture bridges the ‘Valley of Death’4 weeks ago
- International whaling convention needs boosting, not dismantling4 weeks ago
- Don’t dismiss the Montreal ozone-depletion protocol as a ‘zombie’4 weeks ago
- To tackle social-media harms, mandate data access for researchers4 weeks ago
- How a bacterial immune system gets taken apart4 weeks ago
- The biology of smell is a mystery — AI is helping to solve it4 weeks ago
- African scientists must not be priced out of mental-health research4 weeks ago